SCHEMBL25375255

SCHEMBL25375255

CC(C)(C)OC(=O)NCCNc1ccc(Br)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.46
STK17B O94768 1/20 0.46
STK17A Q9UEE5 1/20 0.46
MALT1 Q9UDY8 1/20 0.45
LATS1 O95835 1/20 0.43
FPR3 P25089 3/20 0.43
FPR2 P25090 3/20 0.43
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
SCN9A Q15858 1/20 0.41
BRD4 O60885 2/20 0.40
SUV39H2 Q9H5I1 1/20 0.40
CKS1B P61024 1/20 0.40
SKP1 P63208 1/20 0.40
SKP2 Q13309 1/20 0.40
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8250962 0.86 KMT2A (0.51) BCHESTK17BSTK17AMALT1LATS1
SCHEMBL22174752 0.84 BCHE (0.46) BCHESTK17BSTK17AMALT1LATS1
SCHEMBL27260537 0.83 P4HTM (0.50) BCHESTK17BSTK17AMALT1LATS1
SCHEMBL24205509 0.83 BCHE (0.46) BCHESTK17BSTK17AMALT1LATS1
SCHEMBL4901469 0.82 FPR3 (0.55) BCHEMALT1LATS1FPR3FPR2
SCHEMBL26494561 0.82 GABRA5 (0.51) BCHESTK17BSTK17ALATS1CA1
SCHEMBL14623867 0.81 MALT1 (0.46) BCHESTK17BSTK17AMALT1LATS1
SCHEMBL4910310 0.80 NAMPT (0.51) CA1CA12CA9
SCHEMBL29372463 0.80 NAMPT (0.51) CA1CA12CA9
SCHEMBL18650610 0.80 BCHE (0.43) BCHESTK17BSTK17AMALT1LATS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 EP disclosed
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-06-05 US disclosed
EP-4482583-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2025-01-01 EP disclosed
WO-2023161316-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS MRPL21, WIZ, CFTR BCHE 3763/4885STK17B 2286/4885STK17A 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.